• NatureSynthetic

Associated products


Our Abpromise guarantee covers the use of ab66555 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Purity70 - 90% by HPLC.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • 41 kDa ubiquitin specific protease
    • 41 kDa ubiquitin-specific protease
    • Deubiquitinating enzyme 2
    • Ubiquitin carboxyl terminal hydrolase 2
    • Ubiquitin carboxyl-terminal hydrolase 2
    • ubiquitin specific peptidase 2
    • Ubiquitin specific processing protease 2
    • Ubiquitin specific protease 12
    • Ubiquitin specific protease 9
    • Ubiquitin specific protease, 41kD
    • Ubiquitin thioesterase 2
    • Ubiquitin thiolesterase 2
    • Ubiquitin-specific-processing protease 2
    • Ubiquitin-specific-processing protease testis
    • UBP-t
    • UBP2_HUMAN
    • UBP41
    • USP2
    • USP9
    see all
  • FunctionHydrolase that deubiquitinates polyubiquitinated target proteins such as MDM2, MDM4 and CCND1. Isoform 1 and isoform 4 possess both ubiquitin-specific peptidase and isopeptidase activities. Deubiquitinates MDM2 without reversing MDM2-mediated p53/TP53 ubiquitination and thus indirectly promotes p53/TP53 degradation and limits p53 activity. Has no deubiquitinase activity against p53/TP53. Prevents MDM2-mediated degradation of MDM4. Plays a role in the G1/S cell-cycle progression in normal and cancer cells. Plays a role in the regulation of myogenic differentiation of embryonic muscle cells.
  • Tissue specificityExpressed in mesangial cells of the kidney and in different types of glomerulonephritides (at protein level).
  • Sequence similaritiesBelongs to the peptidase C19 family. USP2 subfamily.
  • DomainThe different N-terminus extensions of isoform 1 and isoform 4 determine their respective subcellular localization and differentiel effect on myoblast fusion and accumulation of muscle-specific proteins. The different N-terminus extensions of isoform 1 and isoform 4 are not essential for their catalytic activity.
  • Cellular localizationNucleus and Cytoplasm. Cytoplasm > perinuclear region. Localizes in the spermatid head in late-elongating spermatids in the thin area between the outer acrosomal membrane and the plasma membrane.
  • Information by UniProt

References for Human USP2 peptide (ab66555)

ab66555 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab66555.
Please use the links above to contact us or submit feedback about this product.